Navigation Links
NSF International Acquires David Begg Associates
Date:9/10/2007

Acquisition Provides Expanded Services to the Pharmaceutical and Biotech

Industries

ANN ARBOR, Mich. and KIRKBYMOORSIDE, England, Sept. 10 /PRNewswire- USNewswire/ -- NSF International (NSF), an independent, not-for-profit organization committed to providing public health protection, today announced the acquisition of David Begg Associates (DBA), an organization that provides professional, high-quality training and auditing solutions to the pharmaceutical and healthcare industries.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070816/DCTH039LOGO )

Together, both NSF and DBA will provide unmatched technical services that will support the testing and training needs of pharmaceutical and biotech companies. Key stakeholders who will benefit from this acquisition include manufacturers of pharmaceuticals, retailers and consumers.

"In fulfilling one of our key strategic objectives, we are delighted to become part of NSF International, an organization like ourselves, founded on and developed through sound ethical principles and core values," said Bob Pietrowski, Managing Partner at DBA. "We are confident that this partnership will bring significant benefits to both parties, and we look forward to the prospect of bringing our unparalleled GMP and regulatory training and auditing expertise to a broader international client base."

Established in 1986, DBA has an international reputation in the field of pharmaceutical quality management, regulatory compliance and training. DBA's leading position in the United Kingdom will give NSF an expanded presence in the European market, while providing additional training services to meet the unique needs of clients worldwide.

"This is an outstanding opportunity for both organizations to expand our global biotech services," said Kevan P. Lawlor, NSF CEO and President. "Combining DB
'/>"/>

SOURCE NSF International
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Olympics of biotechnology has international flavor
2. Traffic data firm navigates international business
3. Catalyst International profit exceeds expectations
4. Lack of broadband hamstrings international videoconferencing
5. 30 days to success: Three simple steps to create your own international startup
6. TEKLYNX International announces new RFID software
7. Ruling enforces international trademark electronic filing requirements
8. Eleftheriou to lead Catalyst International
9. Internet trademark war goes international
10. International eyes drawn to Madisons games research
11. Plexus and SRI International team up to offer medical product development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Washington , July 30, 2015 ... Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial ... Discovery & Development, Preclinical, Clinical Trial), by End Users ... Biosimulation Market is expected to reach USD 2,107.99 million ... a CAGR of 15.29%. Browse more ...
(Date:7/30/2015)... , July 30, 2015   Aratana ... pet therapeutics company focused on the licensing, development ... animals, today announced that its strategic partner VetStem ... dose confirmation study of AT-016, an adipose-derived allogeneic ... the treatment of osteoarthritis pain in dogs. ...
(Date:7/30/2015)... 2015  With over 60,000 customers across the globe, ISN improves the efficiency and ... with more than 60,000 safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers ... Headquartered in Dallas, TX , ISN has ...
(Date:7/30/2015)... HIGHLIGHTS:Q2 2015 Results (all changes ... Reported sales were $697 million compared to $701 million ... by 8%, and changes in foreign currency exchange rates ... 1%. , By business unit, organic sales growth ... in SAFC Commercial. , Reported diluted EPS was ...
Breaking Biology Technology:Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... Premier Research Group plc, the,international pharmaceutical services ... buyout. As a result, the company is no,longer ... Stock Exchange. The UK-based,private equity firm ECI Partners ... Simon Yaxley, Chief Executive Officer of Premier Research,Group, ...
... Inc. (OTC,Bulletin Board: AGGX.OB) a New York-based biotechnology ... targeted anti-angiogenic drugs, announced the,appointment of William Garland ... Hoffmann La Roche, Inc., has directed research and,development ... companies such as,Centaur Pharmaceuticals, Atairgin Technologies, Lpath Therapeutics, ...
... 10 Spine surgeons at Pine Creek Medical,Center ... of a,cutting-edge surgical procedure that utilizes a patient,s ... Douglas Won, Michael Rimlawi, and Francisco J. Battle, ... stem cells,during routine spinal procedures and delivering those ...
Cached Biology Technology:Premier Research Announces Completion of Management Buyout 2AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 2AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 3Spine Surgeons at Pine Creek Medical Center Take the Lead in Utilizing Stem Cell Technologies in Surgical Procedures 2
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
(Date:7/2/2015)... June 25, 2015 ... addition of the "Natural Language Processing Market ... IVR, OCR, Pattern & Image Recognition) - Worldwide ... The key vendors occupying the market ... Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute Inc., ...
(Date:6/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ... America Biomedical Sensors Market - Growth, Trends & Forecasts ... Latin America Biomedical Sensors market is estimated at $0.65 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2
... enzyme viewed as an executioner, because it can push cells ... of cell death, researchers at Emory University School of Medicine ... by leading scientists to rethink how proposed anti-cancer and anti-inflammatory ... to work. The results are described in this week,s ...
... may be behind a progressively earlier bloom of a crucial ... the entire food chain and carbon cycling in the region. ... Diego, along with colleagues in Portugal and Mexico, plotted the ... the ocean food chainin the Arctic Ocean and found the ...
... WEST LAFAYETTE, Ind. - A Purdue University scientist ... of improved plant growth regulators that are expected to ... professor of horticulture, said the growth inhibitors block the ... throughout the plant, controls growth processes. Current growth regulators ...
Cached Biology News:Jekyll and Hyde: Cells' executioner can also stave off death 2Scripps oceanography researchers discover arctic blooms occurring earlier 2New growth inhibitors more effective in plants, less toxic to people 2
... Features, Special optically clear polystyrene formulation ... performance in immunoassay applications , Plates ... lower coefficients of variation , Eight-well ... elimi-nating strip loss while in use even ...
...
... Easy-Titer Human IgM Assay Kit to address ... easy-to-perform assay for Human IgM that eliminates ... incorporates a simple mix-and-read assay that allows ... 15-500 ng/ml in approximately 30 minutes. The ...
... clarification reagent; Ideal for clarifying many ... proteins, nucleic acids, & proteoglycans; Contains ... improves downstream processing; Utilizes a reagent ... supplied as a suspension in saline; ...
Biology Products: